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Despite the importance of immune variation for the
symptoms and outcome of Lyme disease, the factors
influencing cytokine production during infection with
the causal pathogen Borrelia burgdorferi remain
poorly understood.Borrelia infection-inducedmono-
cyte- and T cell-derived cytokines were profiled in
peripheral blood from two healthy human cohorts
of Western Europeans from the Human Functional
Genomics Project. Both non-genetic and genetic
host factorswere found to influenceBorrelia-induced
cytokine responses. Age strongly impaired IL-22 re-
sponses, and genetic studies identified several inde-
pendent QTLs that impact Borrelia-induced cytokine
production. Genetic, transcriptomic, and functional
validation studies revealed an important role for
HIF-1a-mediated glycolysis in the cytokine response
toBorrelia. HIF-1apathwayactivation and increase in
glycolysis-derived lactate was confirmed in Lyme
disease patients. In conclusion, functional genomics
approaches reveal the architecture of cytokine pro-
duction induced by Borrelia infection of human pri-
mary leukocytes and suggest a connection between
cellular glucose metabolism and Borrelia-induced
cytokine production.
INTRODUCTION
Lyme disease is the most common human vector-borne disease
in the United States and Western Europe, and it is transmitted822 Cell Host & Microbe 20, 822–833, December 14, 2016 ª 2016 Elthrough infected ticks (Oosting et al., 2016). The disease is
caused by bacteria of the species Borrelia burgdorferi sensu
lato, including B. burgdorferi sensu stricto, B. afzelii, and
B. garinii as the major causative species. The clinical picture of
Lyme disease is highly variable, ranging from early localized dis-
ease resulting in inflammation of the skin around the tick bite (er-
ythemamigrans [EM]) to disseminated infections, such as neuro-
borreliosis and carditis. Furthermore, chronic or persistent forms
of the disease are seen, resulting in long-term inflammation of
large joints or the skin. In Borrelia-infected tissue or cultures of
human cells exposed to the pathogen, high levels of cytokines
and chemokines, including IL-1b and IL-17, have been detected
(Bachmann et al., 2010; Burchill et al., 2003; Kuo et al., 2011;
Shin et al., 2007). A crucial step in the induction of cytokine
production by monocytes or macrophages is the recognition
of pathogens, which is mainly mediated by pattern recognition
receptors (PRRs). In recent years, several PRRs have been
described to recognize ligands of Borrelia microorganisms, re-
sulting in the induction of specific cytokine responses. Toll-like
receptor (TLR) 2 together with nucleotide-binding oligomeriza-
tion domain (NOD) 2 were shown to play an important role in
the induction of cytokines after Borrelia recognition, whereas
TLR10 was shown to have an inhibitory role in the Borrelia-medi-
ated immune responses (Oosting et al., 2010, 2011a, 2014).
A large diversity is also seen in the induction of host defense,
such as antibody and cytokine responses, in Borrelia-infected
patients. Earlier research has shown that genetic variation in
patients with Lyme disease strongly affects cytokine responses,
ultimately leading to variation in clinical outcome (Oosting et al.,
2011b). Additionally, other studies reported that non-genetic
host factors, such as age, gender, vitamin intake, nutritional sta-
tus, or smoking habits, can influence susceptibility to infectious
or inflammatory diseases (Fish, 2008; Franceschi and Campisi,
2014; Khoo et al., 2012; Libert et al., 2010).sevier Inc.
Despite the importance of immune variation for the symptoms
and outcome of Lyme disease, no comprehensive understand-
ing of the genetic and non-genetic factors influencing the cyto-
kine production induced by Borrelia is currently available. A
missing link between unraveling the genetic factors predisposing
to Lyme disease and the translation into therapeutic targets is
the understanding of the functional consequences of disease-
associated genetic variation. Several questions therefore arise:
what is the overall pattern of cytokine responses after stimulation
of human primary leukocytes with Borrelia, how is this impacted
by genetic variation and non-genetic factors, and lastly, do these
factors influence susceptibility and clinical outcome in patients?
To address these questions, we profiled Borrelia-induced
monocyte-derived and T cell-derived cytokines in two large co-
horts of 500 and 200 healthy individuals of Western European
ancestry from the Human Functional Genomics Project (500
Functional Genomics Project: 500FG and 200FG cohorts). We
delineated inter-individual variability of Borrelia-induced cyto-
kine production in the context of other microbial challenges, as
also described in studies in Cell by ter Horst et al. (2016) and Li
et al. (2016b), and we identified genetic loci that regulate Borre-
lia-mediated immune responses. Regulatory pathways identified
through this genomic approach were validated in immunologic
and transcriptomic studies.
RESULTS
Borrelia-Induced Cytokine Production Clusters
Together with Intracellular Bacteria
To determine whether Borrelia spirochetes induce a pathogen-
specific cytokine profile, we exposed peripheral blood mononu-
clear cells (PBMCs) from 500 healthy volunteers toBorrelia burg-
dorferi s.s., Borrelia mix (i.e., equal amounts of B. burgdorferi,
B. afzelii, andB. garinii), Staphylococcus aureus,Mycobacterium
tuberculosis (Mtb), orEscherichia coli (E. coli) for 24 hr and7days.
Overall, while inducing strong IL-1b and IL-6 responses, Borrelia
induced almost no TNF-a production (Figures 1A and 1E). This
was not due to experimental problems, as substantial TNF-apro-
ductionwas seen after stimulationwith LPS (Figure 1H). Next, we
assessed the correlation betweenBorrelia-induced cytokinepro-
duction and cytokines induced by other intra- (i.e., Mtb) or extra-
cellular bacteria (i.e., E. coli or S. aureus). A strong resemblance
was found between the monocyte-derived cytokine profile
induced by Borrelia and those induced by E. coli and Mtb but
very littlewithS. aureus-inducedcytokines (FigureS1). Adifferent
pattern emerged for the T cell-derived cytokines; B. burgdorferi
and Borrelia mix cluster together, producing significant IL-22
and IL-17 but far less IFN-g compared to the other stimuli tested
(Figure 1C). Nevertheless, the strongest correlation on T cell-
derived cytokines after Borrelia stimulation was again seen with
the intracellular bacterium Mtb (Figure 1D).
To detect the presence of high and low responders to Borrelia
exposure, we analyzed the distribution of cytokine production.
Only Borrelia-induced IL-1b production was found to follow a
normal (Gaussian) distribution (Figure 1E), while the production
of all other measured cytokines was skewed to the right (Figures
1E–1H). This may be partially explained by the substantial
amount of low responders (cytokine production below detection
limit) seen for TNFa, IL-17, and IFN-g.The Role of Non-genetic Factors for B. burgdorferi-
Induced Cytokine Production
It has already been known that lifestyle influences immune
responses, specifically cytokine production upon exposure to
pathogens (Franceschi and Campisi, 2014; Libert et al., 2010).
To detect differences in cytokine production after Borrelia expo-
sure,we analyzed several factors, including previous exposure to
tick bites, gender, body mass index (BMI), smoking habits, age,
and vitamin D serum levels using a linear mixed model. Previous
exposure to tick bites did not influenceBorrelia-induced cytokine
production (Figure 2A) regardless of the number of bites (data not
shown). Stratifying on gender, BMI, smoking habits, and levels of
circulating vitamin D did not affect cytokine production either
(Figure 2A). Of high interest, however, age was found to have
an important impact onBorrelia-induced cytokines in T cells (Fig-
ure 2A). PBMCs of elderly individuals produced significantly less
IL-22 and IFN-g after 7 days of Borrelia exposure, while no age-
dependent effect was observed on IL-17 concentrations (Fig-
ure 2B). The same pattern was seen for Mtb stimulation, further
strengthening the resemblance between the immune responses
to Borrelia and Mtb. To determine whether previous exposure
to Borrelia alters cytokine production upon (re-)stimulation with
B. burgdorferi,M. tuberculosis, S. aureus, or E. coli, we stratified
healthy individuals from the 200FGcohort based on the presence
or absence of antibodies (IgG or IgM) against Borrelia (Figures
2C–2F; Figure S2). No differences in cytokine production, either
monocyte-derived or T cell-derived, could be detected between
individuals having positive or negative serology to Borrelia.
Genome-wide Mapping Identifies Borrelia-Specific
eQTLs
Genetic factors have been described to influence cytokine pro-
duction by immune cells and are able to strongly influence clinical
outcome in disease (Netea et al., 2012). Therefore, we assessed
genetic factors that specifically influence Borrelia-induced
cytokine production. Cytokine production quantitative trait loci
(cQTLs) analysis was performed as described (Li et al., 2016a).
To correct for multiple testing, we set the threshold for genome-
wide statistical significance at p < 53 108. However, using this
threshold, only two cQTLs achieved genome-wide significance:
rs17615278, located in the non-coding RNA transcript RP11-
92J19.3, and rs11103976, located in MGAT4C, which codes for
a glycosyltransferase protein. Both of these expression QTLs
(eQTLs) were found for Borrelia burgdorferi-induced, but not Bor-
relia-mix-induced, IFN-g production (Figure 3A). To increase our
sensitivity for eQTLs affectingBorrelia-mix-induced cytokine pro-
duction, we also analyzed cQTLswith p values between 13 105
and 13 108 for IL-22, IFN-g (Figures 3B and 3C), IL-1b, and IL-6
(TableS1). To rule out that theseeQTLswere foundbychance,we
performed validation in a separate cohort of healthy individuals
(200FG). 55 top cQTLs for Borrelia-induced cytokines (Table S1)
were also analyzed in the 200FG cohort, and 54/55 could be repli-
cated for at least one cytokine (nominal p value < 0.05), including
the two genome-wide significant cQTLs.
Expression QTL Mapping Reveals Genes Involved in
Borrelia-Induced Cytokine Production
To identify the causal genes influenced by the detected cQTL
SNPs, we performed eQTL mapping using RNA sequencingCell Host & Microbe 20, 822–833, December 14, 2016 823
Figure 1. Similarities and Differences of Bor-
relia to Several Other Bacteria
(A) Principal Component Analysis (PCA) bi-plot
based on the monocyte-derived cytokines (IL-6,
TNF-a, and IL-1b). Each dot represents one in-
dividual’s cytokine response against a particular
stimulus; the colors indicate the different stimuli. The
vectors indicate the importance of the original vari-
ables (cytokines) in creating the PCA axis system.
The closer the points cluster along a vector, the
higher the production for that cytokine.
(B) Correlation coefficients after 24 hr of stimulation
with S. aureus,M. tuberculosis, E. coli, Borreliamix,
and B. burgdorferi for the monocyte-derived cyto-
kines IL-1b, IL-6, and TNF-a, calculated using
Spearman rank correlation.
(C) PCA bi-plot based on the T cell-derived cyto-
kines (IL-17, IL-22, and IFN-g).
(D) Correlation coefficients after 7 days of stimula-
tion with S. aureus, M. tuberculosis, Borrelia mix,
and B. burgdorferi for the T cell-derived cytokines
IL-17, IL-22, and IFN-g.
(E and F) Distributions of the monocyte-derived (E)
or T cell-derived (F) cytokine responses for
B. burgdorferi. The red lines indicate upper and
lower thresholds of the ELISA measurement, and
the black line indicates the best fitting theoretical
Gaussian distribution.
(G) Heatmap showing the distribution of cytokine
levels from the 500FG cohort. Red indicates normal
distribution and white indicates non-normal distri-
bution according to the Shapiro-Wilk normality test.
Gray indicates that these cytokine distributions
could not be tested.
(H) TNF-a production (pg/mL) after 24 hr stimulation
with lipopolysaccharide (LPS).
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Figure 2. Effect of Non-genetic Factors on
the B. burgdorferi-Induced Cytokine Pro-
duction
(A) Heatmap depicting the statistical significance
of the correlation between several non-genetic
factors and cytokine production. Darker colors
indicate higher levels of significance; red and blue
cells correspond to positive and negative correla-
tions, respectively. A gray cell means no analysis
could be performed.
(B)Plot showing thecorrelationbetween age (x axis)
and production of IFN-g, IL-17, or IL-22 after 7 days
incubation (y axis, pg/mL in log10 values).
(C–F) Production of IL-1b (C), IL-6 (D), IFN-g (E),
or IL-17 (F) by PBMCs from individuals with either
negative (N) or positive (P) serology againstBorrelia.
Cytokines weremeasured after stimulation for 24 hr
(CandD; n = 81 [N] and n=31 [P]) or 7 days (E andF;
n = 90 [N] and n = 41 [P]) with medium (RPMI),
B. burgdorferi (B.b.), M. tuberculosis, S. aureus
(S.a.), or E. coli (E.c.).data from 629 subjects in another separate cohort, the LL-DEEP
cohort (Tigchelaar et al., 2015).We analyzed the top 20 cQTLs per
Borrelia-induced cytokine and found 46 eQTLs (Table S1).
Pathway analysis indicates that the eQTL genes are mainly
involved in regulating general cellular responses, such as devel-
opment and response to chemicals but also detection of bacterial
lipopeptides (Table S2). However, enrichment analysis showed
no specific pathway to be significantly overrepresented after
correction for multiple testing. We therefore continued by assess-
ing the eQTLs individually. The most interesting eQTL identifiedCell Host & Micwas SNP rs55710213, which affects the
mRNA expression of HIF1AN, encoding
for the factor inhibiting HIF-1a (FIH-1), as
seen in Figure 3D. This SNP significantly
impacts IL-22 levels in PBMCs stimulated
with Borrelia species while having less
effect on Mtb and no effect at all on
S. aureus stimulations (Figure 3E). Effect
of this SNP was also seen, although
weaker, on IL-17 production, but not in
IFN-g production (Figures 3F and 3G).
HIF-1a Regulation of Glucose
Metabolism Is a Crucial Process for
Borrelia-Induced Cytokine
Production
We identified a SNP regulating the ex-
pression of the factor inhibiting HIF-1a
as an important variable in Borrelia-
induced cytokine production. HIF-1a is
a transcription factor with a crucial role
in regulating glucose metabolism, the
response tohypoxia, and toantigenicstim-
ulation (Sakamoto and Seiki, 2010; Scholz
et al., 2016; Zhang et al., 2010). This sug-
gests that cellular glucose metabolism
may be important in Borrelia-induced
cytokine production. To investigate this,we performed transcriptomic analysis on Borrelia-stimulated
PBMCs from a previously published study (Smeekens et al.,
2013). These data revealed significant upregulation of enzymes
and transcription factors involved in the glycolysis pathway and
downregulation of genes involved in the citric acid (TCA) cycle
(Figures 4A–4C).
To confirm these findings, we performed functional assays to
assess the activity of the glycolysis pathway and oxidative meta-
bolism after stimulation. Corresponding to the transcriptomic
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Figure 3. cQTL Analysis
(A–C) Manhattan plots showing the genome-wide QTL mapping results for
B. burgdorferi-induced IFN-g (A) and Borreliamix-induced IL-22 (B) and IFN-g
(C). Horizontal dashed lines correspond to p < 53 107 (IFN-g) or p < 13 105
(IL-22).
(D) Dot plot showing the expression levels, normalized by TMM method
(trimmed mean of m values) (Robinson and Oshlack, 2010) of HIF1AN among
the different genotypes for SNP rs55710213.
(E–G) Functional confirmation of SNP rs55710213 in the 500FG cohort. IL-22
(E), IL-17(F), and IFN-g (G) production in pg/mL from PBMCs stimulated for
7 days. Values on the x axis represent the different genotypes; 0 = TT, 1 = CT,
2 = CC.
826 Cell Host & Microbe 20, 822–833, December 14, 2016significantly more glucose and produce more lactate than unsti-
mulated cells, leading to an increased extracellular acidification
rate (Figure 4D). However, despite decreased transcriptional
activity of genes in oxidative metabolism, no significant change
was detected in oxygen consumption rate (OCR; Figure 4E).
These findings indicate that Borrelia indeed modulates glucose
metabolism in PBMCs, mostly by increasing the glycolysis
pathway.
Previously, the PI3K/Akt/mTOR pathway was shown to be
involved in initiating the metabolic switch toward aerobic glycol-
ysis (Warburg effect) after stimulation (Gerriets and Rathmell,
2012; Weichhart et al., 2015). To test whether this is also the
case after Borrelia stimulation, we analyzed protein expression
of p-AKT and the downstream target of mTOR, p-4EBP1. As
shown in Figure 4F, Borrelia stimulation increased activation
of these signaling molecules, thereby supporting a role for the
involvement of the PI3K/mTOR signaling pathway. To assess
the role of the glucose metabolism pathways for Borrelia-
induced cytokine production, we stimulated PBMCs with Borre-
lia in the presence of pharmacological inhibitors. Pretreatment of
the cells with the glycolysis inhibitor 2-deoxyglucose (2-DG)
drastically decreased production of IL-22 induced by Borrelia
(Figure 4G). This effect was also seen for IL-1b, TNF-a, and
IL-6 and the T cell-derived cytokines IFN-g and IL-17 (Figures
S3A–S3E). Conversely, complete shutdown of oxidative phos-
phorylation (OXPHOS) by the combined action of rotenone and
antimycin A had no effect on cytokine production (Figure 4G,
second panel). All inhibitors were checked for cytotoxicity by
Annexin V/PI flow cytometry staining to rule out cell death as a
confounding factor (Figure S4A).
Additionally, to analyze whether the PI3K/mTOR pathway
is also involved in Borrelia-induced cytokine production, we
treated the cells with the Akt-inhibitor wortmannin and the
mTOR-inhibitors rapamycin and Torin1 and analyzed the pro-
duction of IL-22 (Figure 4G). Interestingly, while mTOR inhibition
significantly decreased IL-22 production, Akt inhibition actually
showed a trend toward increasing IL-22 production. This may
indicate uncoupling of these pathways in the case of Borrelia
stimulation. Inhibiting HIF-1a significantly decreased production
of IL-22 as well; however, this was accompanied by a substantial
amount of cell death, as determined by Annexin V staining
(Figure S4B). To further strengthen the association between
HIF-1a-induced glycolysis and the immune response against
Borrelia, we performed experiments on murine cells with an
HIF-1a deficiency in the myeloid lineage. As seen in Figures 5A
and 5B, cytokine production was reduced in HIF-1a knockout
bone-marrow-derived macrophages (BMDMs) compared to
Figure 4. Borrelia-Induced Changes in Glucose Metabolism
(A) Heatmap of microarray data depicting genes in the glycolysis and TCA cycle pathway significantly affected by Borrelia stimulation in healthy PBMCs (n = 48).
(B) qPCR confirmation of a representative selection of genes in healthy PBMCs (n = 7) stimulated with Borrelia.
(C) Graphical representation of enzymes and transcription factors in central metabolic pathways, whose expression was significantly affected by Borrelia
stimulation (green arrows, upregulation; red arrows, downregulation). Figure was designed in the MindtheGraph platform. *p < 0.05, paired t test.
(D) Functional analysis of glycolysis pathway activity measured by glucose consumption and lactate production after several time points and confirmed by
measuring extracellular acidification rate (ECAR) in healthy PBMCs after 24 hr stimulation with B. burgdorferi (B.b.) (n = 6).
(legend continued on next page)
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Figure 5. Borrelia Stimulation in HIF-1a–/– Cells
Production of innate cytokines, TNF-a (A) and IL-6 (B), and lactate (C) was determined from cell culture supernatants of HIF-1a/murine bone-marrow-derived
macrophages after 24 hr of stimulation with Borrelia burgdorferi (106 spirochetes/mL). Production of T cell-derived cytokines, IL-22 (D) and IL-17 (E), and lactate
(F) was determined in cell culture supernatants from murine spleen cells with an HIF-1a knockout in the myeloid lineage (n = 5) after 6 days of stimulation with
Borrelia burgdorferi (106 and 107 spirochetes/mL, respectively), Candida albicans (C.a.), or anti-CD3/anti-CD28 antibodies.wild-type (WT) cells after 24 hr stimulation with Borrelia. Corre-
spondingly, lactate production was significantly lower in HIF-
1a/ BMDMs compared to WT cells (Figure 5C). These effects
were not seen in spleen cells (Figures 5D–5F), which is not sur-
prising, as these consist mainly of T cells, and the HIF-1a defi-
ciency was restricted to cells of the myeloid lineage. All together,
these data show that Borrelia strongly increases the glycolysis
pathway in healthy PBMCs, predominantly through the mTOR/
HIF-1a pathway, and that activation of this pathway is essential
for cytokine production.
Enhanced HIF-1a Expression and Lactate Production in
Patients with Early Lyme Disease
To determine whether HIF-1a-mediated glucose metabolism is
also involved in patients, we analyzed PBMC transcriptomic
profiles of 29 patients with physician-documented EM from a
previously published study (Bouquet et al., 2016). These data
corroborated our in vitro findings, with HIF1A mRNA being
significantly upregulated in PBMCs at the time of diagnosis
(T = 0) and 2weeks thereafter (T = 2w). Correspondingly,HIF1AN
was significantly downregulated at T = 0 (Figures 6A and 6B).
After 6 months, the expression levels of both HIF1A and
HIF1AN were normalized. In addition, other genes in the glycol-
ysis pathway, such as HK2, PFKFB3, and LDHA, were also(E) Functional analysis of mitochondrial metabolism measured by oxygen cons
termediates in the TCA cycle after 24 hr stimulation with Borrelia.
(F) Western blots of phospho-Akt and phospho-4E-BP1 after 2 hr stimulation wit
(G) Effect of inhibition of the glycolysis pathway (n = 5), oxidative phosphorylation (
IL-22 production. R/A, combination of Rotenone and Antimycin A (concentration
828 Cell Host & Microbe 20, 822–833, December 14, 2016significantly upregulated in acute Lyme patients (Figures 6C–
6E). Finally, we determined the serum concentration of lactate,
the end product of glycolysis, in a separate cohort of patients
with recent onset Lyme disease. In line with the enhanced
HIF1A and decreased HIF1AN expression, we showed that
serum lactate is elevated shortly after Borrelia infection (Fig-
ure 6F). All together, these results underscore the involvement
of glucose metabolism in immune cells for the host response
against Borrelia infection.
DISCUSSION
Cytokines are a crucial component of the immune system, and
they play an important role in both the antimicrobial host de-
fense, as well as in the pathophysiology of immune-mediated
diseases. This is also the case for Lyme disease, but little is
known regarding the variability in these responses between indi-
viduals. The Human Functional Genomics Project investigates
the variability of human immune responses in general, with a
specific interest in cytokine responses. We report the overall
impact of environmental (ter Horst et al., 2016) and genetic (Li
et al., 2016b) host factors, as well as the microbiome (Schirmer
et al., 2016) for modulating cytokine responses to microbial
and non-microbial stimulation. In the present study, we focusedumption rate (OCR) and measurements of fumarate and succinate, two in-
h RPMI or Borrelia. Image was cropped.
OXPHOS) (n = 6), mTOR (n = 6), HIF-1a (n = 5), or Akt (n = 6) onBorrelia-induced








































































































































Figure 6. Transcriptomic Analysis of PBMCs from Lyme Disease Patients
(A–E) Gene expression in FPKM (fragments per kilobase million) of HIF1A (A), HIF1AN (B), HK2 (C), PFKFB3 (D), and LDHA (E) in healthy controls (HC; n = 13)
versus EM patients (n = 28) at different time points. Data were obtained from a publicly available dataset (Bouquet et al., 2016), GEO: GSE63085.
(F) Serum lactate concentrations in a cohort of healthy controls (n = 22) compared to EM patients (n = 58) sampled at different time points. *p < 0.05, **p < 0.01.on deciphering the functional and genetic architecture of the
Borrelia-induced cytokine responses.
The general cytokine profile in PBMCs stimulated with two
preparations of Borrelia and several other pathogens was as-
sessed. It should be noted that this model reflects the systemic
response to the bacterium rather than the initial inflammatory
response, which occurs locally in the skin. No large differences
were seen between the responses to Borrelia alone or the Bor-
relia mix. When comparing with other bacterial stimuli, the Bor-
relia-induced cytokine profile most closely resembled that of
Mtb. Biologically, this is an important observation, as Mtb and
Borrelia are both recognized by a combination of both mem-
brane-bound (TLR2) and intracellular (NOD2) receptors, while
the extracellular bacteria are largely recognized by mem-
brane-bound receptors only (Kleinnijenhuis et al., 2011, 2012;
Oosting et al., 2010, 2011a). The early cytokine responses
seem therefore to follow a recognition receptor-oriented
pattern. This is in line with the overall architecture of cytokine
responses reported by Li et al. (2016a), which are pathogen
centered, rather than immune pathway centered. Another
important observation is the differential regulation of Borrelia-
induced Th1 and Th17 cell-derived cytokine production: while
high production of both IL-17 and IL-22 were observed, IFN-g
production remained low. The latter may be an important obser-
vation, as it may represent a strategy of the microorganism to
evade host defense. Strong induction of IL-22, but not IL-17,
by Borrelia has been previously reported (Bachmann et al.,
2010). This difference may rely on the short exposure time in
this previous investigation, as we recently demonstrated thatT cells, and not NK-cells, are the main source of IL-22 and IL-
17, as well as IFN-g, after Borrelia stimulation. A minimum of
4 days exposure to Borrelia in vitro is therefore necessary for in-
duction of IL-17 in PBMCs (Buffen et al., 2016). The relevance
of IL-17 and IL-22 production for the pathophysiology of Lyme
disease is not fully understood, although both cytokines are
reported to play a role in the persistent phase of the disease
(Codolo et al., 2008; Kotloski et al., 2008). It is known that IL-
22 is important in epithelial skin barrier function and therefore
might play a role in dissemination of the spirochetes (Aujla
and Kolls, 2009; Bachmann et al., 2010). Additionally, genetic
variations affecting IL-22 production have been previously
shown to affect susceptibility to tuberculosis (Zhang et al.,
2011) or candidiasis (De Luca et al., 2013).
Next, we assessed the effect of non-genetic host factors on
cytokine responses to Borrelia. These appeared to play a limited
role, with the notable exception of age. Increasing age strongly
decreased Borrelia-dependent IL-22 production, and this effect
wasmore pronounced forBorrelia than for other stimuli (ter Horst
et al., 2016). This may have important implications, as this could
indicate higher susceptibility to Lyme disease in the elderly. It is
already known that the incidence of Lyme disease shows a
bimodal age distribution with a peak incidence in individuals
aged 50–70 (Berglund et al., 1995; F€ulo¨p and Poggensee,
2008; Nelson et al., 2015), though it is difficult to distinguish bio-
logical age-related factors from behavioral factors. Additionally,
several disseminated Lyme disease symptoms, such as acro-
dermatitis chronica atrophicans (ACA), are known to be more
prevalent in elderly individuals (Mullegger, 2004).Cell Host & Microbe 20, 822–833, December 14, 2016 829
Surprisingly, neither previous exposure to tick bites, nor previ-
ous encounters with the spirochete, defined by the presence of
Borrelia antibodies, influenced the cytokine response. Lastly,
one of the most important aims of the present study was the
identification of the genomic architecture of cytokine responses
in immune cells upon stimulation with Borrelia. Therefore, a
genome-wide association of eight million SNPs with Borrelia-
specific induction of cytokines was performed, and cQTLs influ-
encing both monocyte-derived and T cell-derived cytokines
were identified. Most of these cQTLs encode for genes with un-
known function for the cytokine responses to Borrelia, and
follow-up studies are warranted to investigate their role. It should
be noted that different eQTLs were found for Borrelia burgdor-
feri- andBorrelia-mix-induced cytokines, indicating that different
pathways may be involved in the immune response against the
different Borrelia species. This is also reflected by the fact that
the different species are known to induce different symptoms
(van Dam et al., 1993).
A very interesting link was identified between cellular glucose
metabolism and Borrelia-induced cytokine production. One
of the most significant eQTLs was found for a SNP regulating
the transcription of HIF1AN, encoding for the factor inhibiting
HIF-1a (FIH-1), which significantly affected Borrelia-induced IL-
22 levels. HIF-1a is a transcription factor with a crucial role in
regulating glucose metabolism (Sakamoto and Seiki, 2010;
Scholz et al., 2016; Zhang et al., 2010). In line with this, Borrelia
was found to induce a shift in cellular metabolism toward a War-
burg effect: a switch from oxidative phosphorylation to aerobic
glycolysis, mediated by the mTOR/HIF-1a pathway. This switch
has been previously reported to be involved in cytokine produc-
tion during activation of Th1 (Cham and Gajewski, 2005; Chang
et al., 2013) and, more recently, also Th17 cells (Gerriets et al.,
2015; Michalek et al., 2011) and NK-cells (Keating et al., 2016).
Interestingly, although many previous studies showed the
involvement of the PI3K/Akt pathway in activating mTOR, our
data indicate that IL-22 production after Borrelia stimulation
was Akt independent, yet highly dependent on mTOR. This indi-
cates that mTOR is activated through an unknown alternative
pathway. Although uncommon, similar findings have been
previously reported (Brewer et al., 2007). Nevertheless, our
in vitro data showed that the induction of glycolysis through
the mTOR/HIF-1a pathway is essential for Borrelia-induced
production of IL-22, as well as other cytokines. Furthermore,
experiments in HIF-1a/ bone-marrow-derived macrophages
showed that both cytokine production and lactate production
were decreased compared to WT cells. This strongly supports
a role for HIF-1a-mediated glycolysis in Borrelia-induced cyto-
kine production. Altogether, our data provides evidence that
the glycolysis pathway is physiologically relevant in the human
immune response. Our findings showing a stronger effect of
the HIF1AN eQTL on IL-17 and IL-22 rather than on IFN-g are
supported by Michalek et al. (2011), showing a higher glycolytic
rate in Th17 cells compared to Th1 cells, which could explain the
higher sensitivity to changes in glycolytic flux. In addition, Ger-
riets et al. (2015) provided evidence for an important role for
PDHK1, present in Th17 cells but not in Th1 cells, for glycolysis
and inflammation. Also, transcriptional profiling of leukocytes of
patients with Lyme disease resulted in significantly upregulated
genes in the mTOR-HIF-1a and glycolysis pathway in white830 Cell Host & Microbe 20, 822–833, December 14, 2016blood cells shortly after Borrelia stimulation. In line with these
findings, we found that serum lactate was elevated 2 weeks after
initial diagnosis of Borrelia infection. Furthermore, lactate levels
in cerebral spinal fluid (CSF) were previously shown to be
strongly increased in 63% of Lyme patients with facial palsy,
while CSF lactate was normal in patients with facial palsy due
to other infections (Kindler et al., 2015). Similarly, CSF lactate
was elevated in patients with acute Lyme neuroborreliosis, but
not in patients with neurosyphilis (Djukic et al., 2012). These
data show that a shift of immune cell metabolism toward glycol-
ysis occurs both in vitro and in vivo after an encounter with
Borrelia. This indicates the involvement of a cellular glucose
metabolism pathway in the pathogenesis of Lyme disease and
possibly a target for drug development in long-term immune-
mediated complications.
One of the strongest eQTLs was found for a SNP in MGAT4C
involved in protein glycosylation (Mak et al., 2011), affecting Bor-
relia-induced IFN-g responses. Glycosylation is known to be
crucial for protein function, and recent studies identified defects
in protein glycosylation causing profound immunodeficiency
(Lyons et al., 2015). In addition, very recently it was reported
that MGAT enzymes were linked to metabolic reprogramming
(Ryczko et al., 2016), further supporting the role for metabolism
in Borrelia-induced cytokine production. It is thus tempting to
speculate that protein glycosylation might also be crucial for
anti-Borrelia host defense mechanisms.
In conclusion, we used a functional genomics approach to
describe the architecture of cytokine responses induced by
B. burgdorferi in two large cohorts of healthy volunteers. We
identified several crucial characteristics of Borrelia cytokine re-
sponses, such as a strong correlation with cytokine responses
induced by intracellular bacteria, a strong influence of age on
Borrelia-induced IL-22, and several genomic factors influencing
these responses. Additionally, we demonstrate that a switch in
glucosemetabolism in immune cells is crucial for induction of cy-
tokines by Borrelia. Future studies should aim to unravel the
function of other cQTLs and genes identified here for the immune
responses during Lyme disease.
EXPERIMENTAL PROCEDURES
Borrelia burgdorferi, Borrelia afzelii, and Borrelia garinii Cultures
Borrelia species were cultured at 25C (and in a later time point at 34C) as
described in the Supplemental Experimental Procedures.
Escherichia coli
E. coli ATCC 25922 was grown overnight in culture medium, washed three
times with PBS, and heat-killed for 60 min at 80C. Aliquots were stored at
80C throughout the study.
Staphylococcus aureus
S. aureus strain ATCC 29213 was grown overnight in culture medium, washed
twice with cold PBS, and heat-killed for 30 min at 100C. Aliquots were stored
at 80C throughout the study.
Mycobacterium tuberculosis
Cultures of H37Rv M. tuberculosis were grown to mid-log phase in Middle-
brook 7H9 liquid medium (see Supplemental Experimental Procedures).
Borrelia Serology
Borrelia antibodies were measured using specific ELISAs (Serion/Virion Borre-
lia IgG; ESR-121-G and Borrelia IgM; ESR-121-M) and western blot analysis
(EuroImmunBorrelia IgG and IgM, DY-2131-3001-1G andDY-2131-3001-1M),
both according to the manufacturer’s instructions.
Ethics Statement
The 500 functional genomics study (500FG) was approved by the Ethics
Committee of Radboud University Nijmegen (nr. 42561.091.12). Experiments
were conducted according to the principles expressed in the Declaration of
Helsinki.
500FG and 200FG Cohorts
500FG is a cohort of 500 healthy individuals of Dutch European ancestry from
the Human Functional Genomics Project (www.humanfunctionalgenomics.
org). The cQTLs identified were validated in a second cohort of 200 healthy vol-
unteers working as foresters in the Netherlands. Volunteers were asked to
donate blood in order to determine the serum antibody response against
Borrelia, since Lyme disease occurs as an occupational disease. None of
the volunteers had an active Borrelia infection. In this cohort, all individuals
gave written informed consent to donate an additional blood sample for
research use. General characteristics of the cohorts have been described by
ter Horst et al. (2016).
Isolation of Human PBMCs and Stimulation of Cytokine Production
Venous blood was drawn from the cubital vein of volunteers into 10 mL EDTA
tubes (Monoject). Isolation of PBMCs was performed using Ficoll isolation, as
described in the Supplemental Experimental Procedures. For measurements
of metabolic parameters, see Supplemental Experimental Procedures.
Cytokine Measurements
Human IL-1b, TNF-a, IL-22, IL-17, IFN-ɣ, and IL-6 were determined by using
commercial ELISA kits (PeliKine Compact, Sanquin, or R&D Systems)
according to the manufacturer’s instructions. The sensitivity of all assays
was 20 pg/mL.
Genotyping, Quality Control, and Imputation
DNA samples of 500 individuals were genotyped using the commercially
available SNP chip, Illumina HumanOmniExpressExome-8 v1.0. The genotype
calling was performed using Opticall 0.7.0 (Shah et al., 2012) using the default
settings. Samples with a call rate% 0.99 (n = 18) were excluded from the data-
set as were variants with an HWE% 0.0001 andMAF% 0.001. Potential ethnic
outliers, identified by multi-dimensional scaling plots of our samples merged
with 1000 Genome data (Figure S5), were also excluded (n = 17). This resulted
in a dataset of 442 samples containing both cytokine and genotype information
of 518,980 variants for further imputation. The strands and variant identifiers
were aligned to the reference Genome of the Netherlands (Genome of the
Netherlands Consortium, 2014) dataset using Genotype Harmonizer (Deelen
et al., 2014). The data were phased using SHAPEIT2 v2.r644 (Delaneau
et al., 2013) and imputed using IMPUTE2 (Howie et al., 2011) using the
GoNL as the reference panel (Genome of the Netherlands Consortium,
2014). Post-imputation provided 7,512,899 variants. We selected 4,242,453
SNPs that showed MAFR 5%, INFO scoreR 0.8, and 3 samples per geno-
type for downstream cytokine QTL mapping.
Cytokine QTL Mapping
We used the 500FG dataset as a discovery cohort to identify genome-wide
significant cQTLs since this cohort had the largest numbers of individuals
(n = 489) in which bothBorrelia-stimulated cytokine data and genome informa-
tion was available. The 200FG dataset (n = 78) was used as validation cohort.
See Supplemental Experimental Procedures.
RNA Sequencing, eQTL Expression, and Pathway Analysis
Candidate genes from significant cytokine QTL loci were further tested for
responsiveness to any of the pathogens using RNA sequencing. See Supple-
mental Experimental Procedures for detailed information.
Microarray and qPCR
We obtained previously published transcriptome data for our analysis (GEO:
GSE42606) (Smeekens et al., 2013). See Supplemental Experimental
Procedures.Cell Viability and Metabolite Measurements
Cell survival was analyzed in Borrelia- and medium-stimulated PBMCs using
Annexin V/PI staining as described in the Supplemental Experimental Proced-
ures. Lactate and glucose concentrations in cell culture supernatants were
quantified using Amplex Red reagent (Thermo Fisher Scientific).
Extracellular Flux Measurements
Extracellular acidification rates (ECAR) and oxygen consumption rates (OCR)
were measured using Seahorse XFe96 analyzer (Seahorse Bioscience).
Western Blotting
Western blotting was performed using a TransTurboBlot system (Bio-Rad;
Supplemental Experimental Procedures).
HIF-1a Knockout Experiments
Bone marrow and spleen cells from mice with an HIF-1a deficiency in
the myeloid cell lineage were obtained from Dr. R.A. Cramer (Dartmouth,
NH, USA). Spleen cells were stimulated with B. burgdorferi (106 and 107 spiro-
chetes/mL, respectively), Candida albicans (C.a.), or anti-CD3/anti-CD28
antibodies for 6 days, after which supernatants were collected (Supplemental
Experimental Procedures).
Transcriptome Analysis and Serum Lactate Measurements in Lyme
Patients
RNA sequencing data of acute Lyme patients were obtained from a publicly
available dataset (Bouquet et al., 2016) (GEO: GSE63085). Expression of
selected genes was compared among EM patients at different time points
and healthy controls by Kruskal-Wallis one-way ANOVA with Dunn’s post
hoc t test. Serum lactate concentrations were determined in a Romanian
cohort of clinically proven EM patients and tick-bitten healthy controls. All
patients were included before start of antibiotic treatment (conform IDSA
guidelines), and samples were collected at baseline, after 2 weeks, and after
6 weeks.
Statistical Analysis
The data are expressed as mean ± SEM unless mentioned otherwise.
Differences between experimental groups were tested using the Mann-
Whitney U test performed on GraphPad Prism 4.0 software (GraphPad).
p values of% 0.05 were considered significant.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
five figures, and two tables and can be found with this article online at http://
dx.doi.org/10.1016/j.chom.2016.10.006.
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